MedTrace Logo

Efficacy of Novel Drug-combinations for Relief of Psoriasis

NCT02394301 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2015-05-18

No results posted yet for this study

Summary

ENDURE is a prospective, observational study aimed to document clinical response and side effects associated with compounded psoriasis medications when prescribed as routine care. As a secondary initiative, this study will assess methotrexate systemic absorption and toxicity in patients prescribed a methotrexate-containing compounded formulation.

Conditions

Sponsors & Collaborators

  • Medimix Specialty Pharmacy, LLC

    lead INDUSTRY

Principal Investigators

  • Benjamin J Epstein, PharmD · Medimix Specialty Pharmacy

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02394301 on ClinicalTrials.gov